Overview

I started working for ESMI in Jan 2016 and currently work as an Information Specialist with PenTAG designing and running systematic literature searches for technology appraisals. I also work for the Public Health Reviews team conducting systematic reviews for NIHR.

I previously worked in a variety of roles including as a Senior Information Specialist for NICE, and as an Information Specialist in the NHS at the Homerton Hospital and then in Primary Care in East London. I have also worked in the voluntary sector.

Publications: see https://www.researchgate.net/profile/Sophie_Robinson10/research

1. Barnish MS, Tan SY, Robinson S, Taeihagh A, Melendez-Torres GJ. A realist synthesis to develop an explanatory model of how policy instruments impact child and maternal health outcomes. Social Science & Medicine. 2023 Dec;339:116402.

2. Campbell JL, Fletcher E, Abel G, Anderson R, Chilvers R, Dean SG, et al. Policies and strategies to retain and support the return of experienced GPs in direct patient care: the ReGROUP mixed-methods study. Health Services and Delivery Research. 2019 Apr;7(14):1–288.

3. Coelho H, Price A, Kiff F, Trigg L, Robinson S, Thompson Coon J, et al. Experiences of children and young people from ethnic minorities in accessing mental health care and support: rapid scoping review. Health and Social Care Delivery Research. 2022 Jul;10(22):1–74.

4. Duer E, Yang H, Robinson S, Grigore B, Sandercock J, Snowsill T, et al. Do we know enough about the effect of low-dose computed tomography screening for lung cancer on mortality to act? An updated systematic review, meta-analysis and network meta-analysis of randomised controlled trials 2017 to 2021. Diagnostic and Prognostic Research [Internet]. 2023 Dec;7(1). Available from: http://dx.doi.org/10.1186/s41512-023-00162-0

5. Farmer C, Bullement A, Packman D, Long L, Robinson S, Nikram E, et al. Voretigene Neparvovec for Treating Inherited Retinal Dystrophies Caused by RPE65 Gene Mutations: An Evidence Review Group Perspective of a NICE Highly Specialised Technology Appraisal. PharmacoEconomics. 2020 Sep;38(12):1309–18.

6. Griffin E, Hyde C, Long L, Varley-Campbell J, Coelho H, Robinson S, et al. PCN248 LUNG CANCER SCREENING BY LOW-DOSE COMPUTERISED TOMOGRAPHY: A COST EFFECTIVENESS ANALYSIS OF ALTERNATIVE PROGRAMMES IN THE UNITED KINGDOM USING A NEWLY DEVELOPED NATURAL HISTORY BASED ECONOMIC MODEL. Value in Health. 2020 May;23:S66.

7. Griffin E, Hyde C, Long L, Varley-Campbell J, Coelho H, Robinson S, et al. Lung cancer screening by low-dose computed tomography: a cost-effectiveness analysis of alternative programmes in the UK using a newly developed natural history-based economic model. Diagnostic and Prognostic Research [Internet]. 2020 Dec;4(1). Available from: https://doi.org/10.1186%2Fs41512-020-00087-y

8. Grigore B, Lewis R, Peters J, Robinson S, Hyde CJ. Development, validation and effectiveness of diagnostic prediction tools for colorectal cancer in primary care: a systematic review. BMC Cancer [Internet]. 2020 Nov;20(1). Available from: https://doi.org/10.1186%2Fs12885-020-07572-z

9. Long L, Sansom A, Aylward A, Robinson S, Anderson R, Fletcher E, et al. P72 Understanding why uk gps are leaving general practice–a systematic review of qualitative research. In: SSM annual scientific meeting 2017 [Internet]. BMJ Publishing Group Ltd; 2017. Available from: http://dx.doi.org/10.1136/jech-2017-ssmabstracts.173

10. Long L, Moore D, Robinson S, Sansom A, Aylward A, Fletcher E, et al. Understanding why primary care doctors leave direct patient care: a systematic review of qualitative research. BMJ Open. 2020 May;10(5):e029846.

11. Medina-Lara A, Grigore B, Lewis R, Peters J, Price S, Landa P, et al. Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis. Health Technology Assessment. 2020 Nov;24(66):1–332.

12. Parker H, Frost J, Britten N, Robinson S, Mattick K. Understanding surgical antimicrobial prescribing behaviour in the hospital setting: a systematic review and meta-ethnography protocol. Systematic Reviews [Internet]. 2020 Oct;9(1). Available from: https://doi.org/10.1186%2Fs13643-020-01477-5

13. Parker H, Frost J, Day J, Bethune R, Kajamaa A, Hand K, et al. Tipping the balance: A systematic review and meta-ethnography to unfold the complexity of surgical antimicrobial prescribing behavior in hospital settings. Blumberg S, editor. PLOS ONE. 2022 Jul;17(7):e0271454.

14. Parker HM, Frost J, Britten N, Robinson S, Mattick K. Understanding Surgical Antimicrobial Prescribing Behaviour in the Hospital Setting: A Systematic Review and Meta-ethnography Protocol. 2020 Jul; Available from: http://dx.doi.org/10.21203/rs.3.rs-38937/v1

15. Peters JL, Snowsill TM, Griffin E, Robinson S, Hyde CJ. Variation in Model-Based Economic Evaluations of Low-Dose Computed Tomography Screening for Lung Cancer: A Methodological Review. Value in Health [Internet]. 2021 Dec; Available from: https://doi.org/10.1016%2Fj.jval.2021.11.1352

16. Robinson S, Lawson S. Evaluating the impact of Information Skills Training within primary care. Health information and libraries journal. 2005;22(1):63–5.

17. Snowsill T, Yang H, Griffin E, Long L, Varley-Campbell J, Coelho H, et al. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation. Health Technology Assessment. 2018 Nov;22(69):1–276.

18. Tikhonova I, Long L, Ocean N, Barnish M, Robinson S, Nikram E, et al. PRS50 BENRALIZUMAB FOR TREATING SEVERE EOSINOPHILIC ASTHMA: NICE SINGLE TECHNOLOGY APPRAISAL. Value in Health. 2019 May;22:S358.

19. Tikhonova IA, Bello S, Salmon A, Robinson S, Rezaei Hemami M, Haigh RC, et al. PMS68 PROMONITOR FOR THERAPEUTIC DRUG MONITORING IN PATIENTS WITH SEVERE RHEUMATOID ARTHRITIS TREATED WITH ADALIMUMAB IN ENGLAND AND WALES. Value in Health. 2020 May;23:S227.

20. Tikhonova IA, Jones-Hughes T, Dunham J, Warren FC, Robinson S, Stephens P, et al. Correction to: Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Care Excellence Single Technology Appraisal (PharmacoEconomics, (2018), 36, 1, (39-49), 10.1007/s40273-017-0568-3). PharmacoEconomics. 2018;36(4):507.

21. Tikhonova IA, Jones-Hughes T, Dunham J, Warren FC, Robinson S, Stephens P, et al. Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Care Excellence Single Technology Appraisal. PharmacoEconomics. 2018;36(1):39–49.

22. Tikhonova IA, Yang H, Bello S, Salmon A, Robinson S, Hemami MR, et al. Enzyme-linked immunosorbent assays for monitoring TNF-alpha inhibitors and antibody levels in people with rheumatoid arthritis: a systematic review and economic evaluation. Health Technology Assessment. 2021 Feb;25(8):1–248.

23. Tikhonova I, Jones-Hughes T, Dunham J, Warren F, Robinson S, Hoyle M. PP147 Olaratumab With Doxorubicin For Advanced Soft Tissue Sarcoma. International Journal of Technology Assessment in Health Care. 2018;34(S1):123–4.

24. Yang H, Varley-Campbell J, Coelho H, Long L, Robinson S, Snowsill T, et al. Do we know enough about the effect of low-dose computed tomography screening for lung cancer on survival to act? A systematic review, meta-analysis and network meta-analysis of randomised controlled trials. Diagnostic and Prognostic Research [Internet]. 2019 Nov;3(1). Available from: http://dx.doi.org/10.1186/s415

Publications: see https://www.researchgate.net/profile/Sophie_Robinson10/research

Qualifications

• MA Library and Information Studies
• BA English Literature

Back to top